October 03, 2024

Experts Urged Caution on Mouth Taping Trend

Social media fuels mouth taping trend with 7 million TikTok views, prompting medical experts to scrutinize limited data on forced mouth closure during sleep.

Conexiant

October 03, 2024

Topical Vitamin D with Standard Acne Therapy Reduces Inflammation

A recent study found that topical vitamin D was associated with a reduction in proinflammatory cytokine levels and the severity of inflammatory acne lesions. Additional studies are needed to gain a clearer understanding of its mechanism of action.

Conexiant

October 02, 2024

French Study Uncovers EN Mortality, Sequelae Patterns

French study reveals epidermal necrolysis has 34% one-year mortality rate, with postdischarge deaths linked to acute complications rather than initial disease severity.

Conexiant

September 30, 2024

Thyroid Cancer Radioactive Iodine Tied to Melanoma Risk

New study reveals higher risk of melanoma and nonkeratinocyte skin cancers for thyroid cancer patients treated with radioactive iodine therapy, with particular concern for head and neck region.

Conexiant

September 30, 2024

Roflumilast Cream Effective for Atopic Dermatitis in Phase III Trials

Two phase III clinical trials reveal promising results of once-daily roflumilast cream, 0.15%, in improving symptoms of atopic dermatitis within 4 weeks.

Conexiant

September 25, 2024

Home vs. Office: Psoriasis Treatment Showdown

Home-based narrowband UV-B phototherapy for psoriasis achieved superior treatment adherence, with 51.4% of patients receiving at least 24 treatments compared to only 15.9% in the office-based group.

Conexiant

September 25, 2024

FDA Approves IND for Liquid Botulinum Toxin Formulation

The FDA's approval of YY003 for clinical evaluation introduces a 'safer and more convenient option' with the first-ever liquid botulinum toxin in a pre-filled syringe.

Conexiant

September 23, 2024

Cardiovascular Genes Linked to Psoriasis Risk

Genetic markers for heart disease surprisingly linked to 22% higher psoriasis risk, challenging conventional understanding of their relationship.

Conexiant

September 23, 2024

New Biomarkers Reveal Topical Treatment Effects

Optical coherence tomography reveals betamethasone induces 2.3 times more epidermal thinning than crisaborole in atopic dermatitis patients after 4 weeks of treatment.

Conexiant